At Viatris, we are committed to leveraging our diversified global supply chain to meet the needs of patients. Our broad network of manufacturing facilities across the globe helps to provide significant supply chain resiliency and uninterrupted patient access to medicines. No single country or company can meet the needs of all patients – we are stronger together and are committed to serving patients in ~165 countries around the world. Providing secure access to medicines for patients around the world requires an interconnected, global supply chain; this is why our top 100 products globally are supplied by more than 180 locations from over 35 countries. Our global presence improves our durability in responding to real-time patient and health system needs.

Our strong, global commercial infrastructure enables us to serve patients, wherever they live

~1B
Patients Annually Using Viatris Medicines
165
Countries and Territories
~30,000
Colleagues Worldwide
27
Manufacturing, Packaging & Distribution Sites Worldwide
10
Development Centers

70BN+

Annual dose capacity

~70

Markets with in-country regulatory

~85%

Reach among the Access to Medicine Foundation’s “Access Countries”

20M+

Daily deliveries in 2020: pharmacies, hospitals, and wholesalers

The COVID-19 pandemic has highlighted how interconnected our world is. Well-intentioned public policies closing borders to stem the spread of the virus had vast unintended impacts on supply chains. Through focused efforts in capitals around the world, exceptions had to be made to ensure medicines and other essential products could continue reaching patients, wherever they live.

The solution to cross-border reliance on supply of medicines is not to duplicate production in every country around the world; it is to re-commit in the wake of COVID-19 to strengthening international cooperation and commitment to ensure the free flow of medicines. Policy efforts to increase reliance on domestic sources of essential medicines or otherwise expand the domestic production base should not impede the ability of health systems to respond to the ongoing needs of patients.


Source: Viatris 2025 Sustainability Report

Global Supply Chains for Medicines Public Policy Statement

Secure, reliable access to medicines is best supported by a diverse and agile global supply chain designed to respond quickly to evolving needs. No country can make every medicine it needs, and no medicine is made in every country. Protectionism and localization will not improve overall supply resiliency; policies supporting strong global supply networks are needed.

Read full issue brief